Search Page

1

Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis.

Johnson L, Shapiro M, Mankoff J. Johnson L, et al. Healthcare (Basel). 2018 Oct 12;6(4):124. doi: 10.3390/healthcare6040124. Healthcare (Basel). 2018. PMID: 30322049 Free PMC article.

Lyme disease is caused by the bacteria borrelia burgdorferi and is spread primarily through the bite of a tick. There is considerable uncertainty in the medical community regarding the best approach to treating patients with Lyme disease who do not respond fully to …

Lyme disease is caused by the bacteria borrelia burgdorferi and is spread primarily through the bite of a tick. There is considerable …

Cite

Share

2

Chronic Lyme disease and the 'Axis of Evil'.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Future Microbiol. 2008 Dec;3(6):621-4. doi: 10.2217/17460913.3.6.621. Future Microbiol. 2008. PMID: 19072179 Review.

Lyme disease is a controversial illness, and the existence of chronic Lyme disease induced by persistent infection with the Lyme spirochete, Borrelia burgdorferi, is the subject of continued debate. A recent publication defined the 'Axis of Evil' in this cont …

Lyme disease is a controversial illness, and the existence of chronic Lyme disease induced by persistent infection with the …

Cite

Share

3

Lyme disease: the promise of Big Data, companion diagnostics and precision medicine.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Infect Drug Resist. 2016 Sep 13;9:215-9. doi: 10.2147/IDR.S114770. eCollection 2016. Infect Drug Resist. 2016. PMID: 27672336 Free PMC article.

Lyme disease caused by the spirochete Borrelia burgdorferi has become a major worldwide epidemic. Recent studies based on Big Data registries show that >300,000 people are diagnosed with Lyme disease each year in the USA, and up to two-thirds of individuals infec …

Lyme disease caused by the spirochete Borrelia burgdorferi has become a major worldwide epidemic. Recent studies based on Big Data re …

Cite

Share

4

Treatment of Lyme disease: a medicolegal assessment.

Johnson L, Stricker RB. Johnson L, et al. Expert Rev Anti Infect Ther. 2004 Aug;2(4):533-57. doi: 10.1586/14787210.2.4.533. Expert Rev Anti Infect Ther. 2004. PMID: 15482219 Review.

Lyme disease is the most common tick-borne disease in the world today. Despite extensive research into the complex nature of Borrelia burgdorferi, the spirochetal agent of Lyme disease, controversy continues over the diagnosis and treatment of this protean illness. …

Lyme disease is the most common tick-borne disease in the world today. Despite extensive research into the complex nature of Borrelia …

Cite

Share

5

Lyme disease: the next decade.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Infect Drug Resist. 2011;4:1-9. doi: 10.2147/IDR.S15653. Epub 2011 Jan 7. Infect Drug Resist. 2011. PMID: 21694904 Free PMC article.

Concurrent clinical implementation of proteomic screening offers a chance to correct significant deficiencies in Lyme testing. Advances in these areas have the potential to revolutionize the diagnosis and treatment of Lyme disease in the coming decade....

Concurrent clinical implementation of proteomic screening offers a chance to correct significant deficiencies in Lyme testing. Advanc …

Cite

Share

6

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Cameron DJ, Johnson LB, Maloney EL. Cameron DJ, et al. Among authors: Johnson LB. Expert Rev Anti Infect Ther. 2014 Sep;12(9):1103-35. doi: 10.1586/14787210.2014.940900. Epub 2014 Jul 30. Expert Rev Anti Infect Ther. 2014. PMID: 25077519 Free PMC article. Review.

Evidence-based guidelines for the management of patients with Lyme disease were developed by the International Lyme and Associated Diseases Society (ILADS). ...Healthcare providers who evaluate and manage patients with Lyme disease are the intended users of t …

Evidence-based guidelines for the management of patients with Lyme disease were developed by the International Lyme and Associ …

Cite

Share

7

Lyme disease: call for a "Manhattan Project" to combat the epidemic.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. PLoS Pathog. 2014 Jan;10(1):e1003796. doi: 10.1371/journal.ppat.1003796. Epub 2014 Jan 2. PLoS Pathog. 2014. PMID: 24391491 Free PMC article. Review. No abstract available.

Cite

Share

8

Lyme disease: a turning point.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Expert Rev Anti Infect Ther. 2007 Oct;5(5):759-62. doi: 10.1586/14787210.5.5.759. Expert Rev Anti Infect Ther. 2007. PMID: 17914908 No abstract available.

Cite

Share

9

Lyme disease vaccination: safety first.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Lancet Infect Dis. 2014 Jan;14(1):12. doi: 10.1016/S1473-3099(13)70319-0. Lancet Infect Dis. 2014. PMID: 24355028 No abstract available.

Cite

Share

10

Spirochetal 'debris' versus persistent infection in chronic Lyme disease: from semantics to science.

Stricker RB, Johnson L. Stricker RB, et al. Among authors: Johnson L. Future Microbiol. 2012 Nov;7(11):1243-6. doi: 10.2217/fmb.12.92. Future Microbiol. 2012. PMID: 23075442 No abstract available.

Cite

Share